The Annual General Meeting of the RACI WA Branch and Groups will be held at the Chem Centre at Curtin University on Tuesday 12 November. The short AGM will be held, followed by a Chemaraderie speaker.
The AGM is an important part of the year. The AGM takes up only a short portion of the evening, with the majority of the time being networking and the evening presentation. It would be hoped that most members can find time in their schedules to attend.
National RACI has generously provided some funding for this event this year, so the event will be catered with delicious hot and cold food. Food will be served from 5.30pm (so arrive nice and early), and again after the Chemaraderie speaker concludes.
Chemaraderie Speaker: Associate Professor Matt Piggott, University of Western Australia, School of Molecular Sciences. matthew.piggott@uwa.edu.au
Chemaraderie Title: Drug Discovery in the Piggott Group
Biography
Associate Professor Matt Piggott is a teaching & research academic medicinal chemist in the School of Molecular Sciences at the University of Western Australia (UWA). He graduated from UWA with majors in Chemistry, and Biochemistry/Molecular Biology, and a PhD in natural product total synthesis under Dieter Wege in 2000. His first postdoctoral appointment, with Martin Banwell and Chris Easton in the Research School of Chemistry, ANU, involved antibiotic drug discovery in collaboration with GlaxoSmithKline. He then worked with T. Ross Kelly, at Boston College, towards a chemically powered molecular motor, before returning to the ANU to take up a lectureship in the Department of Chemistry in 2003. In 2005, Matt returned to UWA.
Matt has extensive experience in drug discovery and pre-clinical development for cancer, trypanosomiasis, neuropsychiatric conditions, Parkinson's disease and other neurodegenerative disorders. He is cofounder and director of Setonix Pharmaceuticals, a start-up spun-out from UWA and the Telethon Kids Institute. Matt has sponsored collaborations with local and international biotech companies – Emyria Ltd., Perth, https://emyria.com; NeuroVigor Therapeutics, Indiana, USA, www.nvtherapeutics.com; Microbial Screening Technologies Pty Ltd., Sydney www.microbialscreening.com – and has previously collaborated with/consulted for, GSK, Eboo Pharmaceuticals, Atuka, Recce Pharmaceuticals, and Anteris Technologies.
With thanks to our Chemaraderie sponsor
Event Terms & Conditions
Cancellation Policy D applies to this event. For full details, view our Cancellation Policy. By registering for this event, you agree to, and will be bound by, the RACI Event Terms and Conditions and Event Code of Conduct.
Do you belong to a reciprocal society?
Complete this form for access to the reciprocal member rate.
Not yet a member of RACI?
Join now to enjoy a discount on registration for this event.
Please note: Online registration is required prior to the conclusion of the event. Cash payment cannot be accepted on the evening.
#WA